Did health economics fail us during the COVID-19 pandemic?

Telehealth through the lens of value-based care in the US

HTA Quarterly | Fall 2021

Update: The impact of obesity on COVID-19 outcomes of hospitalizations and mortality

Manufacturers

Work worth doing: FormularyDecisions

HTA Quarterly | Summer 2021

Manufacturers

Launching field services in the midst of COVID-19

The impact of obesity on COVID-19 outcomes of hospitalizations and mortality

Manufacturers

Evaluating the modern field reimbursement and access program: key considerations

HTA Quarterly | Winter 2020

Manufacturers

Ebook: Virtual drug commercialization

Manufacturers

PAP 2020 panel recap: Navigating COVID-19

COVID-19 Drives Through the American Heartland

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

Manufacturers

Solving access, reimbursement, and PAP awareness problems

Webinar | Navigating COVID-19: Simplifying the Path to Better Patient Outcomes

HTA Quarterly | Fall 2020

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Patient Support in the Time of COVID-19: Five Ways to Adapt

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

HTA Quarterly | Summer 2020

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Manufacturers

Webinar: Patient Assistance in the Wake of COVID19

The Potential Impact of Pharmaceutical and Non-Pharmaceutical Interventions to Mitigate the COVID-19 Crisis in the United States: A Model-Based Analysis

Manufacturers

How COVID-19 Will Impact Patient Support

Impact of COVID-19 Pandemic on Patient Access Programs

Payer Contact in a “Contactless” World: Achieving Early Engagement